SCHEMBL5771594

SCHEMBL5771594

N#Cc1oc(-c2ccc(Cl)cc2)cc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 2/20 0.41
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
KMT2A Q03164 1/20 0.40
BCHE P06276 1/20 0.40
NOTUM Q6P988 2/20 0.40
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
PPARG P37231 1/20 0.38
STAT3 P40763 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5772616 0.84 RAB9A (0.47) TNKSKDM4EALDH1A1HPGDMEN1
SCHEMBL6415752 0.76 KDM4E (0.43) TNKSKDM4EALDH1A1HPGDMEN1
SCHEMBL11564265 0.68 NOTUM (0.53) KDM4EALDH1A1HPGDGAATSHR
SCHEMBL10555140 0.67 ALDH1A1 (0.44) KDM4EALDH1A1HPGDMEN1GAA
SCHEMBL5157357 0.66
SCHEMBL4505454 0.66 KCNA3 (0.44) TNKSKDM4EALDH1A1HPGDMEN1
SCHEMBL3274518 0.66 MCL1 (0.51) KDM4EALDH1A1HPGDMEN1GAA
SCHEMBL4594131 0.66 ALDH1A1 (0.51) KDM4EALDH1A1HPGDMAPTKMT2A
SCHEMBL11611941 0.66 RET (0.42) TNKSKDM4EALDH1A1HPGDGLA
SCHEMBL4256945 0.64 ALDH1A1 (0.51) KDM4EALDH1A1HPGDMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed